Ayaan A Alam
Examiner (ID: 3803)
Most Active Art Unit | 1611 |
Art Unit(s) | 1611 |
Total Applications | 153 |
Issued Applications | 27 |
Pending Applications | 65 |
Abandoned Applications | 61 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18511613
[patent_doc_number] => 20230227782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => HEMATOPOIETIC STEM AND PROGENITOR CELLS DERIVED FROM HEMOGENIC ENDOTHELIAL CELLS BY EPISOMAL PLASMID GENE TRANSFER
[patent_app_type] => utility
[patent_app_number] => 18/147554
[patent_app_country] => US
[patent_app_date] => 2022-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147554
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/147554 | HEMATOPOIETIC STEM AND PROGENITOR CELLS DERIVED FROM HEMOGENIC ENDOTHELIAL CELLS BY EPISOMAL PLASMID GENE TRANSFER | Dec 27, 2022 | Pending |
Array
(
[id] => 17882999
[patent_doc_number] => 20220298476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => METHODS FOR PRODUCING CELL POPULATIONS WITH INCREASED NUCLEIC ACID UPTAKE
[patent_app_type] => utility
[patent_app_number] => 17/732227
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732227
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/732227 | METHODS FOR PRODUCING CELL POPULATIONS WITH INCREASED NUCLEIC ACID UPTAKE | Apr 27, 2022 | Pending |
Array
(
[id] => 18656170
[patent_doc_number] => 20230302049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => METHODS FOR TREATING CANCER AND AUTOIMMUNE AND INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/246231
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246231
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246231 | METHODS FOR TREATING CANCER AND AUTOIMMUNE AND INFLAMMATORY DISEASES | Sep 21, 2021 | Pending |
Array
(
[id] => 17112116
[patent_doc_number] => 20210292713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => METHOD FOR PRODUCING NATURAL KILLER CELLS FROM PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/186877
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/186877 | METHOD FOR PRODUCING NATURAL KILLER CELLS FROM PLURIPOTENT STEM CELLS | Feb 25, 2021 | Pending |
Array
(
[id] => 17049806
[patent_doc_number] => 20210259240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => System and Method for Organ Maintenance and Transport
[patent_app_type] => utility
[patent_app_number] => 17/180506
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180506
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180506 | System and Method for Organ Maintenance and Transport | Feb 18, 2021 | Pending |
Array
(
[id] => 17037047
[patent_doc_number] => 20210254005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => OFF-THE-SHELF STEM CELL AND IMMUNE CELL, AND A PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/156476
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/156476 | OFF-THE-SHELF STEM CELL AND IMMUNE CELL, AND A PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | Jan 21, 2021 | Pending |
Array
(
[id] => 16946542
[patent_doc_number] => 20210205233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => INJECTABLE CRYOGEL VACCINE DEVICES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/083720
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083720
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083720 | INJECTABLE CRYOGEL VACCINE DEVICES AND METHODS OF USE THEREOF | Oct 28, 2020 | Pending |
Array
(
[id] => 16709521
[patent_doc_number] => 20210076668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => ORGAN CONTAINER WITH OXYGENATION OPTION
[patent_app_type] => utility
[patent_app_number] => 17/015443
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17015443
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/015443 | ORGAN CONTAINER WITH OXYGENATION OPTION | Sep 8, 2020 | Pending |
Array
(
[id] => 16466751
[patent_doc_number] => 20200368288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => Hierarchic Neural Microphysiological System for Brain Function and Disorders
[patent_app_type] => utility
[patent_app_number] => 16/992316
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992316
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992316 | Hierarchic Neural Microphysiological System for Brain Function and Disorders | Aug 12, 2020 | Pending |
Array
(
[id] => 16506420
[patent_doc_number] => 20200385676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => GENERATION OF FUNCTIONAL NEUTROPHILS AND MACROPHAGES FROM INDUCED PLURIPOTENT STEM CELLS IN CHEMICALLY DEFINED CONDITIONS USING TRANSIENT EXPRESSION OF ETV2
[patent_app_type] => utility
[patent_app_number] => 16/894569
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894569
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894569 | GENERATION OF FUNCTIONAL NEUTROPHILS AND MACROPHAGES FROM INDUCED PLURIPOTENT STEM CELLS IN CHEMICALLY DEFINED CONDITIONS USING TRANSIENT EXPRESSION OF ETV2 | Jun 4, 2020 | Pending |
Array
(
[id] => 16326907
[patent_doc_number] => 20200297872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9
[patent_app_type] => utility
[patent_app_number] => 16/890666
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890666
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890666 | DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9 | Jun 1, 2020 | Abandoned |
Array
(
[id] => 16326865
[patent_doc_number] => 20200297830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => SEQUENCE ARRANGEMENTS AND SEQUENCES FOR NEOEPITOPE PRESENTATION
[patent_app_type] => utility
[patent_app_number] => 16/874104
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874104
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874104 | SEQUENCE ARRANGEMENTS AND SEQUENCES FOR NEOEPITOPE PRESENTATION | May 13, 2020 | Abandoned |
Array
(
[id] => 16267316
[patent_doc_number] => 20200268803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => USE OF LIFR OR FGFR3 AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/795041
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795041
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795041 | USE OF LIFR OR FGFR3 AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS | Feb 18, 2020 | Pending |
Array
(
[id] => 15862929
[patent_doc_number] => 20200138868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => Compositions for Drug Delivery and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/730603
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16730603
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/730603 | Compositions for Drug Delivery and Methods of Use Thereof | Dec 29, 2019 | Pending |
Array
(
[id] => 15619309
[patent_doc_number] => 20200080059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => GENERATION OF HEMATOPOIETIC PROGENITOR CELLS FROM HUMAN PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/563190
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16563190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/563190 | GENERATION OF HEMATOPOIETIC PROGENITOR CELLS FROM HUMAN PLURIPOTENT STEM CELLS | Sep 5, 2019 | Pending |
Array
(
[id] => 16484235
[patent_doc_number] => 20200377836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => MEMBRANE AND METHOD FOR CULTURE AND DIFFERENTIATION OF CELLS
[patent_app_type] => utility
[patent_app_number] => 16/429042
[patent_app_country] => US
[patent_app_date] => 2019-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16429042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/429042 | MEMBRANE AND METHOD FOR CULTURE AND DIFFERENTIATION OF CELLS | Jun 1, 2019 | Abandoned |
Array
(
[id] => 14778551
[patent_doc_number] => 20190264173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => STEM CELL-DERIVED SCHWANN CELLS
[patent_app_type] => utility
[patent_app_number] => 16/410686
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16410686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/410686 | STEM CELL-DERIVED SCHWANN CELLS | May 12, 2019 | Pending |
Array
(
[id] => 16727844
[patent_doc_number] => 20210094991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/733619
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -114
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733619
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733619 | METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER | Mar 18, 2019 | Pending |
Array
(
[id] => 16627456
[patent_doc_number] => 20210046109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => Suppressive Exosomes in Cancer and for Immunosuppression
[patent_app_type] => utility
[patent_app_number] => 16/980391
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980391 | Suppressive Exosomes in Cancer and for Immunosuppression | Mar 13, 2019 | Pending |
Array
(
[id] => 16511550
[patent_doc_number] => 20200390807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => COMPOSITION AND METHOD FOR TARGETING NATURAL KILLER CELLS IN IMMUNOTHERAPY TO OVERCOME TUMOR SUPPRESSION WITH MANGANESE DIOXIDE NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/971425
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971425
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971425 | COMPOSITION AND METHOD FOR TARGETING NATURAL KILLER CELLS IN IMMUNOTHERAPY TO OVERCOME TUMOR SUPPRESSION WITH MANGANESE DIOXIDE NANOPARTICLES | Feb 19, 2019 | Pending |